Skip to content

Clinical trials

Completed Neurofibromatoses trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurofibromatoses Status: Completed Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20062
20071
20092
20101
20112
20124
20143
20152
20172
20181
20191
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital6
National Cancer Institute (NCI)5
Indiana University2
University of Alabama at Birmingham2
Harry T Whelan, MD1
Kent Robertson1
M.D. Anderson Cancer Center1
Medical College of Wisconsin1
Memorial Sloan Kettering Cancer Center1
National Institute of Mental Health (NIMH)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurofibromatoses27
Neurofibromatosis 111
Neurofibroma6
Neurofibroma, Plexiform4
Neurofibromatosis 24
Neoplasms3
Abdominal Neoplasms1
Anemia, Sickle Cell1
Angiofibroma1
Brain Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.